Contents
Contents
The False Claims Act government action bar raises a question we work through with you: how an existing government proceeding relates to the fraud you know about. If an agency is already asking about the billing you know about, the fact that someone is investigating does not answer the filing question. We examine the government’s role, the conduct at issue and what your information adds. An insider deserves more than an assumption that somebody else has it covered.
The False Claims Act names civil suits and administrative civil money penalty proceedings in which the government is already a party. We look at what those proceedings cover and how they connect to the conduct you know about before a qui tam case is filed.
A hospital’s billing vendor can influence the claims the hospital submits. A medical-device supplier can pay physicians who use its products. Understanding the work and the payments helps explain why two cases concern the same alleged scheme, or why they concern different conduct altogether. The court decisions below show both the business relationships and the government’s role.
Whether an investigation matters to your case is something we work through with you. An investigation, an existing civil case and the evidence you hold each need attention before a decision about filing.
The law gives the government a role in investigating allegations and deciding whether to take over a whistleblower case. Taking over is called intervention.
A civil investigative demand is a tool for obtaining evidence. The Congressional Research Service describes the government’s authority to compel documents and testimony during its investigation.
A criminal investigation or criminal case can run alongside civil work concerning the same facts. That overlap is another reason to speak with us about the conduct you know about.
Existing civil cases show why the allegations and the government’s participation matter together. A billing vendor’s advice and a hospital’s claims can be connected parts of the same alleged conduct.
The Ninth Circuit’s 2017 decision concerning Biotronik involved a medical-device supplier and allegations that it paid physicians to use its products. An earlier whistleblower alleged that the company used paid speaking engagements, advisory boards, entertainment and sham clinical studies to reward physicians. The alleged studies concerned doctors who prescribed its pacemakers and implantable cardiac defibrillators. The allegation was that payments presented as compensation for professional activities bought the use or endorsement of the supplier’s devices.
The government joined the earlier whistleblower case and settled allegations involving expensive meals and advisory-board payments without proper documentation of the work performed. That settlement did not cover the alleged sham clinical studies. A later complaint supplied more detail about those studies and other allegations outside the settlement, but did not allege new claims.
The court found that the clinical-study allegations were already part of the earlier case. In its ruling, once the government joined, the whole case counted, even the claims it never settled.
We see the mismatch: the settlement left out the alleged sham studies, but the earlier case still included them. The settlement told only part of the story.
The April 30, 2025 decision concerning Geisinger Holy Spirit involved a different business relationship: hospitals and a vendor reviewing whether patients qualified for inpatient care. The whistleblower alleged that the hospitals relied on Executive Health Resources to support billing Medicare and Medicaid at higher inpatient rates for services that should have been billed at lower outpatient rates.
The court described the review process. A hospital committee could decide that a patient did not qualify for inpatient status, then a physician adviser could conduct a second review. The hospital submitted the payment claim after that review. The whistleblower alleged that the vendor improperly reversed decisions against inpatient status, allowing hospitals to bill at the higher rate.
The same whistleblower had previously brought a case against Executive Health Resources concerning that alleged scheme. The government later asked the court to dismiss that earlier case. The later case focused on hospital clients, including Geisinger Holy Spirit, that allegedly used the vendor’s policies and submitted the claims.
The court found that the hospital case covered the same alleged scheme as the vendor case. The earlier complaint had already described Holy Spirit’s billing practices extensively, even though it had not named that hospital as a defendant. The vendor’s review and the hospital’s bill were connected parts of the same alleged conduct. For someone working in utilization review or hospital billing, that is the recognizable relationship: one business advises on the classification, another submits the claim.
The Geisinger court also discussed a 1998 case against URS Consultants in which earlier government proceedings concerned responsibility for environmental-cleanup costs. The whistleblower case concerned allegedly false payment claims for the cleanup work. The appellate court had rejected the government action bar because those fraud allegations or transactions were absent from the earlier proceedings.
The project was the same. The alleged wrong was different. We want to understand that difference in the work itself, whether it concerns a treatment classification, a physician payment or a bill for contracted services.
An administrative civil money penalty proceeding is the other category the law names. It concerns an agency proceeding over a civil monetary penalty. We examine the agency’s documents and the alleged conduct with you and whistleblower counsel experienced in False Claims Act government proceedings.
The Congressional Research Service’s 2009 report, Qui Tam: The False Claims Act and Related Federal Statutes, describes a shift away from excluding whistleblower suits based on information already in government hands. The change brought insiders back into the fight against fraud:
The 1986 amendments reinvigorated qui tam procedures in the face of the evidence of extensive fraud against the United States.
Qui Tam: The False Claims Act and Related Federal Statutes, Congressional Research Service, 2009
Government awareness is where this conversation starts. What you know about the conduct belongs in it too.
Another case is a reason to speak with us about its relationship to what you know. The government action bar, first-to-file and public disclosure are separate issues that we assess with you and experienced False Claims Act whistleblower lawyers.
The False Claims Act allows a whistleblower to continue a case when the government declines to take it over. When the government takes over, it runs the case. The court can also let the government join later. We bring in False Claims Act whistleblower lawyers to address what that means for your case. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If an agency is investigating your company or an existing case concerns the billing or payments you understand, speak with our whistleblower experts about what you know. We help build your strongest False Claims Act case around what you know, with whistleblower lawyers who understand overlapping government proceedings. From the first conversation through the case, we are your experts and partners.